ArticleClinical, cosmetic and investigational dermatology2026
Photodynamic Therapy Combined with Surgery: An Effective Treatment for Keloids via the YAP/Engrailed-1 Signaling Pathway.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Keloid, a unique human ailment, poses challenges in scar treatment due to variable efficacy and lengthy therapy and follow-up periods. Therefore, there is a need for a novel approach to address all forms of abnormal scarring. Photodynamic therapy (PDT), although slow-acting, shows promise, particularly when combined with surgery. This study aims to assess the efficacy and potential mechanism of PDT in conjunction with surgery for keloid treatment. Methods: Keloid patients were identified through pathological examination, and the expression of YAP and Engrailed-1 in keloid tissue was determined via immunohistochemistry. Initially, all keloids underwent treatment with 20% ALA-PDT as the initial therapeutic step (the preoperative photodynamic therapy margin extends 0.5 cm beyond the visible lesion edge to ensure full target tissue coverage), using red LED light with specific parameters. Subsequently, keloids were surgically excised 24 hours post-PDT, followed by another PDT session. Results: Immunohistochemistry assays revealed a significant reduction in YAP and Engrailed-1 levels in keloid tissues post-PDT. Over a minimum 6-month follow-up period, no infections, scar exacerbations, or recurrences were observed, except for postoperative hyperpigmentation. Conclusion: The combination of PDT and surgical therapy demonstrates promising results for keloid treatment. The suppression of YAP leading to reduced Engrailed-1 expression may represent a mechanism underlying the successful treatment of keloids with PDT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.